Chinese expert consensus on the management of hypertension in adults with type 2 diabetes

Diabetes and Obesity Research Group of Chinese Diabetes Society (CDS) and Chinese Hypertension League (CHL)

doi:10.1111/jebm.12655

Chinese expert consensus on the management of hypertension in adults with type 2 diabetes

Diabetes and Obesity Research Group of Chinese Diabetes Society (CDS) and Chinese Hypertension League (CHL)

Sichuan University
Army Medical University
Chongqing Institute of Hypertension
Shanghai Jiao Tong University
Nanjing University
Guangdong Academy of Medical Sciences
Guangdong Institute of Cardiovascular Disease
Hebei Medical University
Renmin Hospital of Wuhan University
Ministry of Health of People's Republic of China
National Center of Geriatics and Gerotology
Shanghai University
Hebei General Hospital
Shenyang General Hospital of PLA
Military Cardiovascular Disease Research Institute
Capital Medical University
Xinjiang Uygur Autonomous Region People's Hospital
PLA Rocket Force Characteristic Medical Center
Shanghai Institute of Hypertension
Fudan University
First Affiliated Hospital of Zhengzhou University
Peking University
The First Affiliated Hospital of Xi’an Jiaotong University
Zunyi Medical University
The Eighth Affiliated Hospital of Sun Yat-Sen University
First Affiliated Hospital of Sun Yat sen University
Central South University
First Affiliated Hospital of University of South China
Fujian Medical University
The Second Affiliated Hospital of Xi'an Jiaotong University
Southern Medical University
Hubei Provincial Hospital of TCM
The Second Affiliated Hospital of Chongqing Medical University
Chinese Academy of Medical Sciences
Sir Run Run Shaw Hospital
Shandong First Medical University & Shandong Academy of Medical Sciences
Tianjin Medical University

科研成果: 期刊稿件 › 文章 › 同行评审

12 引用（Scopus）

摘要

Both hypertension and type 2 diabetes are attributable to premature death, cardiovascular and kidney diseases with largely overlapping population. Followed the GRADE approach, this expert consensus aimed to reduce the cardiovascular and kidney death and disability due to hypertension and minimize the treatment burden in adults with type 2 diabetes. Through online survey and discussion, a multidisciplinary team comprehensively prioritized seven key guideline questions. Informed by the evidence synthesis and online discussion, the team developed 12 recommendations under the GRADE Evidence-to-decision (EtD) framework. The recommendations covered the screening of hypertension in adults diagnosed with type 2 diabetes but not hypertension and the monitoring, lifestyle interventions, and medications in those diagnosed with type 2 diabetes and hypertension.

源语言	英语
页（从-至）	851-864
页数	14
期刊	Journal of Evidence-Based Medicine
卷	17
期	4
DOI	https://doi.org/10.1111/jebm.12655
出版状态	已出版 - 12月 2024
已对外发布	是

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

可持续发展目标 3 良好健康与福祉

访问文件

10.1111/jebm.12655

其它文件与链接

链接到 Scopus 的出版物

引用此

@article{fd41a81bfbd14c6c9d24b3cc83fac4a9,

title = "Chinese expert consensus on the management of hypertension in adults with type 2 diabetes",

abstract = "Both hypertension and type 2 diabetes are attributable to premature death, cardiovascular and kidney diseases with largely overlapping population. Followed the GRADE approach, this expert consensus aimed to reduce the cardiovascular and kidney death and disability due to hypertension and minimize the treatment burden in adults with type 2 diabetes. Through online survey and discussion, a multidisciplinary team comprehensively prioritized seven key guideline questions. Informed by the evidence synthesis and online discussion, the team developed 12 recommendations under the GRADE Evidence-to-decision (EtD) framework. The recommendations covered the screening of hypertension in adults diagnosed with type 2 diabetes but not hypertension and the monitoring, lifestyle interventions, and medications in those diagnosed with type 2 diabetes and hypertension.",

keywords = "anti-hypertensive treatment, blood pressure monitor, hypertension, screening for hypertension, type 2 diabetes",

author = "\{Diabetes and Obesity Research Group of Chinese Diabetes Society (CDS) and Chinese Hypertension League (CHL)\} and Xiaohui Pan and Hongbo He and Yuqian Bao and Yan Bi and Luyuan Chen and Xiaoping Chen and Hui Fang and Wenhuan Feng and Ling Gao and Lixin Guo and Yifang Guo and Yaling Han and Qi Hua and Nanfang Li and Quanmin Li and Yan Li and Yong Li and Xialian Li and Jing Liu and Huijuan Ma and Jianjun Mu and Kailei Nong and Huiqian Shang and Yunfeng Shen and Zhongwei Shi and Fang Sun and Ningling Sun and Jun Tao and Jiguang Wang and Xinling Wang and Jing Wu and Xinhua Xiao and Liangdi Xie and Jing Xu and Jing Xu and Hongying Ye and Dongni Yu and Hong Yuan and Huijie Zhang and Jian Zhang and Lili Zhang and Yuqing Zhang and Jiaqiang Zhou and Xinli Zhou and Dalong Zhu and Tiehong Zhu and Sheyu Li and Zhiming Zhu",

note = "Publisher Copyright: {\textcopyright} 2024 Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley \& Sons Australia, Ltd.",

year = "2024",

month = dec,

doi = "10.1111/jebm.12655",

language = "英语",

volume = "17",

pages = "851--864",

journal = "Journal of Evidence-Based Medicine",

issn = "1756-5383",

publisher = "John Wiley and Sons Inc",

number = "4",

}

TY - JOUR

T1 - Chinese expert consensus on the management of hypertension in adults with type 2 diabetes

AU - Diabetes and Obesity Research Group of Chinese Diabetes Society (CDS) and Chinese Hypertension League (CHL)

AU - Pan, Xiaohui

AU - He, Hongbo

AU - Bao, Yuqian

AU - Bi, Yan

AU - Chen, Luyuan

AU - Chen, Xiaoping

AU - Fang, Hui

AU - Feng, Wenhuan

AU - Gao, Ling

AU - Guo, Lixin

AU - Guo, Yifang

AU - Han, Yaling

AU - Hua, Qi

AU - Li, Nanfang

AU - Li, Quanmin

AU - Li, Yan

AU - Li, Yong

AU - Li, Xialian

AU - Liu, Jing

AU - Ma, Huijuan

AU - Mu, Jianjun

AU - Nong, Kailei

AU - Shang, Huiqian

AU - Shen, Yunfeng

AU - Shi, Zhongwei

AU - Sun, Fang

AU - Sun, Ningling

AU - Tao, Jun

AU - Wang, Jiguang

AU - Wang, Xinling

AU - Wu, Jing

AU - Xiao, Xinhua

AU - Xie, Liangdi

AU - Xu, Jing

AU - Ye, Hongying

AU - Yu, Dongni

AU - Yuan, Hong

AU - Zhang, Huijie

AU - Zhang, Jian

AU - Zhang, Lili

AU - Zhang, Yuqing

AU - Zhou, Jiaqiang

AU - Zhou, Xinli

AU - Zhu, Dalong

AU - Zhu, Tiehong

AU - Li, Sheyu

AU - Zhu, Zhiming

PY - 2024/12

Y1 - 2024/12

N2 - Both hypertension and type 2 diabetes are attributable to premature death, cardiovascular and kidney diseases with largely overlapping population. Followed the GRADE approach, this expert consensus aimed to reduce the cardiovascular and kidney death and disability due to hypertension and minimize the treatment burden in adults with type 2 diabetes. Through online survey and discussion, a multidisciplinary team comprehensively prioritized seven key guideline questions. Informed by the evidence synthesis and online discussion, the team developed 12 recommendations under the GRADE Evidence-to-decision (EtD) framework. The recommendations covered the screening of hypertension in adults diagnosed with type 2 diabetes but not hypertension and the monitoring, lifestyle interventions, and medications in those diagnosed with type 2 diabetes and hypertension.

AB - Both hypertension and type 2 diabetes are attributable to premature death, cardiovascular and kidney diseases with largely overlapping population. Followed the GRADE approach, this expert consensus aimed to reduce the cardiovascular and kidney death and disability due to hypertension and minimize the treatment burden in adults with type 2 diabetes. Through online survey and discussion, a multidisciplinary team comprehensively prioritized seven key guideline questions. Informed by the evidence synthesis and online discussion, the team developed 12 recommendations under the GRADE Evidence-to-decision (EtD) framework. The recommendations covered the screening of hypertension in adults diagnosed with type 2 diabetes but not hypertension and the monitoring, lifestyle interventions, and medications in those diagnosed with type 2 diabetes and hypertension.

KW - anti-hypertensive treatment

KW - blood pressure monitor

KW - hypertension

KW - screening for hypertension

KW - type 2 diabetes

UR - https://www.scopus.com/pages/publications/85208780290

U2 - 10.1111/jebm.12655

DO - 10.1111/jebm.12655

M3 - 文章

C2 - 39529557

AN - SCOPUS:85208780290

SN - 1756-5383

VL - 17

SP - 851

EP - 864

JO - Journal of Evidence-Based Medicine

JF - Journal of Evidence-Based Medicine

IS - 4

ER -

Chinese expert consensus on the management of hypertension in adults with type 2 diabetes

摘要

联合国可持续发展目标

访问文件

其它文件与链接

学术指纹

引用此